Health
INSIGHT-Fortune or foresight? AstraZeneca and Oxford’s stories clash on COVID-19 vaccine – Devdiscourse
Both AstraZeneca and Oxford University scientists said they had consulted health regulators and were given the go-ahead to continue with the half-dose among a limited…
AstraZeneca and Oxford University have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine, a rare instance of public dissension between major institutions collaborating on a pivotal project. The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose. This diverged from the original plan of two full doses, given…
-
Business24 hours ago5 easy steps to build a $100,000 ASX share portfolio
-
Business21 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Noosa News24 hours agoThe rent crisis behind Australia’s two-faced cities
-
Noosa News21 hours agoThe Almond Ashes sees Australia and India mix business and cricket